<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02303106</url>
  </required_header>
  <id_info>
    <org_study_id>AKF-386</org_study_id>
    <nct_id>NCT02303106</nct_id>
  </id_info>
  <brief_title>Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study</brief_title>
  <official_title>Interaction Between Paracetamol and Lamotrigine: A Clinical Interaction Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Per Damkier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will study the effect of paracetamol on the steady state metabolism of
      lamotrigine in 12 healthy male volunteers.

      Subjects will receive lamotrigine, slowly titrated from 25 mg daily to 100 mg daily over 28
      days. On day 36, full plasma and urine PK samples will be drawn. On days 37-40 the subject
      will be co-administered 1 gr paracetamol 4 times daily. On day 40 the sampling will be
      repeated.

      Primary outcome parameter is Lamotrigine AUC before and after coadministration of
      paracetamol.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lamotrigine AUC</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>lamotrigine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>lamotrigine alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lamotrigine + paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lamotrigine + paracetamol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lamotrigine</intervention_name>
    <arm_group_label>lamotrigine</arm_group_label>
    <arm_group_label>Lamotrigine + paracetamol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy no medication use

          -  Informed consent

        Exclusion Criteria:

          -  Allergy to paracetamol or lamotrigine
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Damkier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head Consultant Clinical Pharmacology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Southern Denmark</name>
      <address>
        <city>Odense</city>
        <zip>5210</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 21, 2014</study_first_submitted>
  <study_first_submitted_qc>November 24, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 27, 2014</study_first_posted>
  <last_update_submitted>April 21, 2015</last_update_submitted>
  <last_update_submitted_qc>April 21, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 22, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Per Damkier</investigator_full_name>
    <investigator_title>Head Consultant, MD, Ph.D.</investigator_title>
  </responsible_party>
  <keyword>AUC exposure to lamotrigine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Lamotrigine</mesh_term>
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

